XENE SEC Filings | SEC Document SEARCH
Back to Search
Xenon Pharmaceuticals Inc. (XENE)
Ticker: XENE
CIK: 0001582313
49
Filings Found (Last 1 Year)
Filter Filings
All
4
2026. 9. 30.
Kelly Thomas Patrick (CIK 0001410514)
Insider trading report
4
Open Filing
4
2026. 9. 30.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
4
2026. 9. 1.
Svoronos Dawn (CIK 0001574579)
Insider trading report
4
Open Filing
4
2026. 8. 28.
KENNEY CHRISTOPHER JOHN (CIK 0001880129)
Insider trading report
4
Open Filing
4
2026. 8. 11.
GANNON STEVEN (CIK 0001643085)
Insider trading report
4
Open Filing
10-Q
2026. 6. 30.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Quarterly report
10-Q
Open Filing
8-K
2026. 8. 6.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
4
2026. 6. 5.
PATOU GARY (CIK 0001283535)
Insider trading report
4
Open Filing
4
2026. 6. 5.
Cannon Gillian (CIK 0001833910)
Insider trading report
4
Open Filing
4
2026. 6. 1.
PATOU GARY (CIK 0001283535)
Insider trading report
4
Open Filing
4
2026. 6. 1.
Machado Patrick (CIK 0001311210)
Insider trading report
4
Open Filing
4
2026. 6. 1.
Gover Justin D. (CIK 0001754129)
Insider trading report
4
Open Filing
4
2026. 6. 1.
GAROFALO ELIZABETH A. (CIK 0001826361)
Insider trading report
4
Open Filing
4
2026. 6. 1.
GANNON STEVEN (CIK 0001643085)
Insider trading report
4
Open Filing
4
2026. 6. 1.
Cannon Gillian (CIK 0001833910)
Insider trading report
4
Open Filing
4
2026. 6. 1.
Svoronos Dawn (CIK 0001574579)
Insider trading report
4
Open Filing
8-K
2026. 6. 2.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
4
2026. 5. 12.
GANNON STEVEN (CIK 0001643085)
Insider trading report
4
Open Filing
10-Q
2026. 3. 31.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Quarterly report
10-Q
Open Filing
8-K
2026. 5. 7.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
8-K
2026. 4. 7.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
4
2026. 3. 12.
KENNEY CHRISTOPHER JOHN (CIK 0001880129)
Insider trading report
4
Open Filing
4
2026. 3. 12.
DiFabio Andrea (CIK 0001692506)
Insider trading report
4
Open Filing
4
2026. 3. 12.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
8-K
2026. 3. 13.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
8-K
2026. 3. 10.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
424B5
2026. 3. 12.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Prospectus
424B5
Open Filing
4
2026. 3. 9.
KENNEY CHRISTOPHER JOHN (CIK 0001880129)
Insider trading report
4
Open Filing
4
2026. 3. 9.
DiFabio Andrea (CIK 0001692506)
Insider trading report
4
Open Filing
4
2026. 3. 9.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
424B5
2026. 3. 9.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Prospectus
424B5
Open Filing
8-K
2026. 3. 9.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
8-K
2026. 2. 27.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
424B5
2026. 2. 27.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Prospectus
424B5
Open Filing
10-K
2025. 12. 31.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Annual report
10-K
Open Filing
8-K
2026. 2. 26.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
4
2026. 1. 9.
KENNEY CHRISTOPHER JOHN (CIK 0001880129)
Insider trading report
4
Open Filing
4
2026. 1. 9.
Cline Darren S (CIK 0001633639)
Insider trading report
4
Open Filing
4
2026. 1. 9.
DiFabio Andrea (CIK 0001692506)
Insider trading report
4
Open Filing
4
2026. 1. 9.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
4
2026. 1. 2.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
4
2025. 12. 5.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
4
2025. 11. 28.
MORTIMER IAN (CIK 0001619961)
Insider trading report
4
Open Filing
8-K
2025. 11. 24.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
10-Q
2025. 9. 30.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Quarterly report
10-Q
Open Filing
8-K
2025. 11. 3.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
4
2025. 10. 15.
Kelly Thomas Patrick (CIK 0001410514)
Insider trading report
4
Open Filing
8-K/A
2025. 10. 15.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
8-K/A
8-K/A
Open Filing
8-K
2025. 10. 15.
Xenon Pharmaceuticals Inc. (XENE) (CIK 0001582313)
Current report
8-K
Open Filing
Previous
Page 1 of 3
Next
